Table 1

Selected baseline characteristics

Amiodarone
(n = 80)
No amiodarone
(n = 150)
p Value
Age (years)56 (1)53 (1)NS
Sex (% male)9680< 0.001
Diagnosis (cardiomyopathy:IHD:other)43:32:584:54:12NS
Duration (months)27 (4)33 (4)NS
NYHA class
 I28NS
 II1431NS
 III4468NS
 IV2043NS
Heart rate (beats/min)82 (1)85 (1)NS
Rhythm
 Sinus50 (63%)126 (84%)
 Atrial fibrillation27 (34%)15 (10%)< 0.0001
 Other3 (3%)9 (6%)
Echocardiographic measurements
 LVEDD (mm)74 (1)73 (1)NS
 LVESD (mm)65 (1)63 (1)NS
 Fractional shortening (%)13 (1)14 (1)NS
 Ejection fraction (%)23 (1)24 (1)NS
6 minute walk (m)408 (15)429 (11)NS
Treatment (%)
 ACE inhibitors 10096NS
 Diuretics 98890.02
 Digoxin7876NS
 Vasodilators5848NS
 Antithrombotic8873< 0.01
  • ACE, angiotensin converting enzyme; IHD, ischaemic heart disease; LVEDD, left ventricular end diastolic dimension; LVESD left ventricular end systolic dimension.